EFFECTIVENESS OF MODERN METHODS OF TREATING TYPE I MUCOPOLYSACCHARIDOSIS PATIENTS
Type I mucopolysaccharidosis (MPS) is a hereditary metabolic disease related to lysosomal storage diseases. Alpha-L-iduronidase enzyme deficiency leads to dissimilar disease phenotypes and varying severity of symptoms. Researchers distinguish between three phenotypes of the disease: Hurler syndrome...
Shranjeno v:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Union of pediatricians of Russia
2014-11-01
|
| Serija: | Педиатрическая фармакология |
| Teme: | |
| Online dostop: | https://www.pedpharma.ru/jour/article/view/40 |
| Oznake: |
Brez oznak, prvi označite!
|
